Prohibitin has also been linked to human prostate cancer through recent investigations establishing that prohibitin associates with the androgen receptor (AR) and participates in AR-mediated gene regulation (Gamble et al. 2007; Gamble et al. 2004). Here, AR is linked to prostate carcinoma.